搜索临床试验以:SAR231893 (REGN668) DP2
总计2687个结果
-
LMC Diabetes & Endocrinology Ltd.Merck Sharp & Dohme LLC; Syreon Corporation撤销2型糖尿病
-
San Antonio Military Medical CenterNuGenerex Immuno-Oncology; Norwell, Inc.完全的
-
Nutrition Institute, SloveniaSlovenian Research Agency; Valens Int. d.o.o., Slovenija; Community Health Centre Ljubljana完全的
-
Concentrx Pharmaceuticals, Inc.PharPoint Research, Inc.; Kramer Consulting, LLC完全的
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers University主动,不招人
-
Mundipharma Research Limited完全的
-
Pieris Pharmaceuticals GmbHFGK Clinical Research GmbH; Nuvisan Pharma Services; EUROCALIN Consortium完全的
-
Peking Union Medical College HospitalThe First Affiliated Hospital with Nanjing Medical University; Peking University People's Hospital 和其他合作者未知
-
University of HelsinkiUniversity College Cork; Technical University of Denmark完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; MedImmune LLC完全的
-
University of PrimorskaBiostile d.o.o.完全的
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.终止
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Conquer Cancer Foundation; St. Baldrick's Foundation招聘中
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)终止
-
Alvogen Korea完全的
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; The First Affiliated Hospital of... 和其他合作者招聘中
-
Otsuka Pharmaceutical Development & Commercialization...完全的
-
SanofiRegeneron Pharmaceuticals完全的